Neoclease was featured in the Boston Business Journal as part of a growing wave of AI-native biotech startups, in an article exploring AI as a foundational engine for discovery, platform development, and therapeutic innovation.
The coverage highlights how a new generation of companies is building on artificial intelligence from the ground up, not bolting it on as an afterthought, to accelerate the design of next-generation therapeutics.